Neoadjuvant Chemoimmunotherapy in Non-small-cell Lung Cancer Patients: Effects on Pulmonary Function and Incidence of Postoperative Pulmonary Complications—A Multicentre Real-World Study
Neoadjuvante Chemoimmuntherapie bei Patient:innen mit nichtkleinzelligem Lungenkarzinom: Effekte auf die Lungenfunktion und das Auftreten postoperativer pulmonaler Komplikationen – multizentrische Real-World-Studie
European Journal of Cardio-Thoracic Surgery · 02.11.2025 · 67 (11)
DOI: 10.1093/ejcts/ezaf351 ↗Auf einen Blick
Bei 386 Patient:innen mit NSCLC war nach neoadjuvanter Chemoimmuntherapie eine eingeschränkte Lungenfunktion mit postoperativen pulmonalen Komplikationen verbunden. 61 Patient:innen entwickelten solche Komplikationen.
Fragestellung
Welche Effekte hat neoadjuvante Chemoimmuntherapie auf die Lungenfunktion und das Auftreten postoperativer pulmonaler Komplikationen bei NSCLC in der Real-World-Praxis?
Methode
Retrospektive Analyse von Patient:innen mit Stadium II–IIIB aus 3 medizinischen Institutionen; klinische Daten und perioperative Outcomes wurden ausgewertet.
Ergebnisse
386 Patient:innen wurden eingeschlossen. 61 entwickelten postoperative pulmonale Komplikationen, 25 davon eine Checkpoint-Inhibitor-assoziierte Pneumonie. Die Mortalität postoperativ lag bei 2,8 % (11/386).
Schlussfolgerung der Autor:innen
Eine eingeschränkte Lungenfunktion nach neoadjuvanter Chemoimmuntherapie ist mit der Entwicklung postoperativer pulmonaler Komplikationen assoziiert.
Kernaussagen
- 61 von 386 Patient:innen entwickelten postoperative pulmonale Komplikationen
- 25 Fälle waren eine Checkpoint-Inhibitor-assoziierte Pneumonie
- Eingeschränkte Lungenfunktion nach Behandlung war ein Risikofaktor
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 16.10.2025. Verfasst von Jian Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jiangxi Clinical Research Center for Respiratory Diseases, The First Affiliated Hospital, Jiangxi Medical College, Na…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy, Postoperative Complications. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
To evaluate the effects of neoadjuvant chemoimmunotherapy on pulmonary function and the incidence of postoperative pulmonary complications in real-world non-small-cell lung cancer patients.
Methods
A retrospective analysis of stage II-IIIB non-small-cell lung cancer patients who received neoadjuvant chemoimmunotherapy across 3 medical institutions was conducted. Clinical data and perioperative outcomes were evaluated.
Results
A total of 386 patients were screened and enrolled in the study cohort, and all patients underwent surgery after completing neoadjuvant chemoimmunotherapy. Postoperatively, 61 patients developed postoperative pulmonary complications, among whom 25 were diagnosed with checkpoint inhibitor-related pneumonia. The postoperative mortality rate was 2.8% (11/386), with all deaths attributed to severe postoperative checkpoint inhibitor-related pneumonia. The diffusing capacity of the lung for carbon monoxide tended to decrease after neoadjuvant chemoimmunotherapy, with 39% of patients developing impaired pulmonary function post-treatment. After controlling for confounding variables via propensity score matching analysis, impaired pulmonary function after treatment was associated with postoperative pulmonary complications. Multivariable logistic regression analysis revealed that prior lung disease (odds ratio, [OR]: 1.63; 95% CI, 1.02-3.31, P = .037), impaired pulmonary function after treatment (OR: 2.78; 95% CI, 1.38-5.24, P < .001), lymph node metastasis (OR: 3.05; 95% CI, 1.65-6.21, P < .001), and elevated preoperative interleukin-6 levels (OR: 1.58; 95% CI, 1.36-1.83, P < .001) were high risk factors for postoperative pulmonary complications.
Conclusions
Impaired pulmonary function after neoadjuvant chemoimmunotherapy is associated with the development of postoperative pulmonary complications. Post-treatment impaired pulmonary function, lymph node metastasis, prior lung disease, and elevated preoperative interleukin-6 levels are risk factors for postoperative pulmonary complications. Clinical Registration Number A Retrospective Study on Pulmonary Function Changes and Safety in Patients Receiving Neoadjuvant Chemoimmunotherapy (IIT2024733).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Jiangxi Clinical Research Center for Respiratory Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
- Department of Thoracic Oncology and Surgery, Guangzhou Institute of Respiratory Health, China State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, The First Affiliated…
- Department of Thoracic Surgery, Southern Hospital, Southern Medical University, Guangzhou 510515, China.
ORCID-Profile: Jian Tang
Zitieren
APA
Zhang, J., Feng, Y., Dai, S., Xu, G., Cheng, B., Jiang, L., Xue, L. P., Liang, W., & Tang, J. (2025). Neoadjuvant Chemoimmunotherapy in Non-small-cell Lung Cancer Patients: Effects on Pulmonary Function and Incidence of Postoperative Pulmonary Complications—A Multicentre Real-World Study. European Journal of Cardio-Thoracic Surgery, 67(11). https://doi.org/10.1093/ejcts/ezaf351
Vancouver
Zhang J, Feng Y, Dai S, Xu G, Cheng B, Jiang L, et al. Neoadjuvant Chemoimmunotherapy in Non-small-cell Lung Cancer Patients: Effects on Pulmonary Function and Incidence of Postoperative Pulmonary Complications—A Multicentre Real-World Study. European Journal of Cardio-Thoracic Surgery. 2025;67(11). doi:10.1093/ejcts/ezaf351
BibTeX
@article{Zhang2025,
author = {Zhang, Jian and Feng, Yi and Dai, Shaohua and Xu, Guoqiu and Cheng, Bo and Jiang, Lei and Xue, Li Peng and Liang, Wenhua and Tang, Jian},
title = {Neoadjuvant Chemoimmunotherapy in Non-small-cell Lung Cancer Patients: Effects on Pulmonary Function and Incidence of Postoperative Pulmonary Complications—A Multicentre Real-World Study},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
volume = {67},
number = {11},
doi = {10.1093/ejcts/ezaf351}
}
EUVIMED